Vivo Capital, a venture fund founded in 1996 in Palo Alto, focuses on healthcare investments, particularly in FemTech, Life Science, Manufacturing, and Healthcare sectors. With a diverse portfolio of companies like PatientPop, Provivi, MacuLogix, Preventice Solutions, and INBRACE, Vivo Capital has made 172 investments and achieved 80 exits. Partnered with Frank Kung, Vivo Capital manages approximately $5.8 billion in assets under management (AUM). The fund invests across various stages, from Pre-Seed to Series D, supporting innovative startups in the healthcare industry. For more information, visit their website at www.vivocapital.com.